Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Augmented reality tool for neglect after stroke

Tests an augmented reality system for stroke patients with neglect, assessing feasibility and acceptability.

Plain-language title generated from the registry record
Registry title: An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

Key facts

Where
Boston and Pittsburgh, United StatesSee the 2 sites

Where in United States

  • Northeastern UniversityBoston, United StatesNot yet recruiting
  • University of PittsburghPittsburgh, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Pittsburgh
Trial code
NCT04187131
Record updated
13 July 2026
Original description
The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.Read full original descriptionShow less

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.

Inclusion: ages18 and older; acute stroke; admitted to inpatient rehabilitation; presence of neglect (Behavioral Inattention Test total score <129, or scoring below pre-defined cutoff score in at least one of the six subtests); more than 10/% missed targets on the Augmented Reality Screening Test; intact vibration (positive test on Vibration Sensation Test); intact auditory function (positive test on Auditory Sensation Test); English speaking.

Exclusion: self-report of previous positive photic stimulation test; current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor; inability to follow one-step directions at least 80% of the time; metal in the head that causes interference with the EEG system.

ClinicalTrials.gov NCT04187131